Lotus Endometriosis Institute releases important update on microRNA research for potential non-invasive blood test to ...

Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful ...

Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways continue to evolve globally helping ...

InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

Endometriosis is a chronic condition affecting approximately 190 million women and teenage girls globally. It can cause ...

Non-invasive prenatal screening techniques can detect chromosomal abnormalities including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). These ...

First women’s health test marks a new chapter for InterVenn, providing access to non-invasive testing that differentiates between cancerous and benign pelvic masses for improved treatment planning ...

Getting an endometriosis diagnosis is often costly, time-consuming and invasive. Now, it could be as easy as a simple blood ...

Promising findings could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful condition that affects nearly 200 million women worldwide. Promising ...

The findings suggested that stool metabolites found in women with endometriosis could be the basis for a non-invasive diagnostic test as well as a potential strategy to reduce disease progression. The ...